Breaking News Instant updates and real-time market news.

MYL

Mylan

$35.94

-0.9 (-2.44%)

08:56
10/10/16
10/10
08:56
10/10/16
08:56

Mylan gaps up sharply in pre-market after reaching deal with DOJ

The shares are up over 12% to $40.29 at time of writing. At that price next resistance is at $41.37. Support is at $39.20.

  • 09

    Nov

  • 28

    Mar

MYL Mylan
$35.94

-0.9 (-2.44%)

10/10/16
UBSW
10/10/16
NO CHANGE
Target $60
UBSW
Buy
UBS remains constructive on Mylan despite governance controversy
UBS analyst Marc Goodman said he remains constructive on Mylan despite the controversy surrounding its corporate governance. Goodman cited the company's ability to execute, its surprise announcement of a EpiPen Medicaid lawsuit settlement and its updated guidance, which was better than feared. Goodman reiterated his Buy rating and lowered his price target to $60 from $66 on Mylan shares.
10/10/16
RAJA
10/10/16
UPGRADE
Target $57
RAJA
Strong Buy
Mylan upgraded to Strong Buy on EpiPen settlement at Raymond James
As previously reported, Raymond James upgraded Mylan two notches to Strong Buy from Market Perform and established a $57 price target. Analyst Elliot WIlbur said the Department of Justice settlement over EpiPen rebates eliminates a significant overhang on shares enabling the focus to be back on fundamentals. With depressed absolute and relative valuation levels, Wilber sees favorable risk/reward scenarios even in a more tempered earnings growth environment.
10/10/16
JPMS
10/10/16
NO CHANGE
Target $52
JPMS
Overweight
Mylan settlement, updated guidance a positive, says JPMorgan
JPMorgan analyst Chris Schott views Mylan's $465M settlement with the Department of Justice relating to the potential misclassification of Epipen in the Medicaid Drug Rebate Program as well as its updated 2016 guidance as a positive. The news "removes litigation overhang at a reasonable cost and highlights the diversification of the base business and inexpensive valuation," Schott tells investors in a research note. He keeps an Overweight rating on Mylan with a $52 price target.
10/10/16
WELS
10/10/16
NO CHANGE
WELS
Mylan settlement does not end EpiPen issue, says Wells Fargo
In a research note titled "Forget After Hrs. Quarterbacking - It is Not Back to Normal," Wells Fargo analyst David Maris says Mylan questions still remain after the company's lowered 2016 outlook and $465M Department of Justice settlement. One of Mylan's earnings levers, EpiPen pricing, is now off the table going forward, Maris tells investors in a research note. The analyst disagrees with investors that think the settlement puts the EpiPen pricing issue largely behind the company. The deal with the DOJ addresses only the Centers for Medicare and Medicaid Services portion of the issue, it does nothing to answer the original issue of EpiPen pricing and consumers, Maris contends. He points out that Mylan also disclosed in Friday's regulatory filing, but not in its press release, an SEC investigation by the Division of Enforcement. Maris says he's "not too excited" and doesn't gauge how good the news is by the after-hours share rally of 10%. He believes Mylan is "not back to normal" and keeps a Market Perform rating on the stock with a $43-$45 price target range. The shares are up 12% in pre-market trading to $40.35. Raymond James this morning upgraded Mylan to Strong Buy.

TODAY'S FREE FLY STORIES

PTCT

PTC Therapeutics

$19.51

0.99 (5.35%)

08:55
09/26/17
09/26
08:55
09/26/17
08:55
Hot Stocks
Breaking Hot Stocks news story on PTC Therapeutics »

PTC Therapeutics drops…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

  • 24

    Oct

AAPL

Apple

$150.55

-1.34 (-0.88%)

, FB

Facebook

$162.87

-7.67 (-4.50%)

08:55
09/26/17
09/26
08:55
09/26/17
08:55
Options
Notable open interest changes for September 26th »

Monday's total…

AAPL

Apple

$150.55

-1.34 (-0.88%)

FB

Facebook

$162.87

-7.67 (-4.50%)

MU

Micron

$34.87

-1.2 (-3.33%)

BABA

Alibaba

$169.59

-8.55 (-4.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 22

    Oct

ORA

Ormat Technologies

$57.57

-0.11 (-0.19%)

08:55
09/26/17
09/26
08:55
09/26/17
08:55
Conference/Events
Ormat Technologies holds an analyst and investor day »

Analyst and Investor Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

GRUB

GrubHub

, AMZN

Amazon.com

$939.79

-15.31 (-1.60%)

08:52
09/26/17
09/26
08:52
09/26/17
08:52
Recommendations
GrubHub, Amazon.com analyst commentary  »

Wedbush remains bullish…

GRUB

GrubHub

AMZN

Amazon.com

$939.79

-15.31 (-1.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

08:50
09/26/17
09/26
08:50
09/26/17
08:50
General news
Treasury 2-year auction outlook: »

Treasury 2-year auction…

W

Wayfair

$71.23

-3.36 (-4.50%)

08:48
09/26/17
09/26
08:48
09/26/17
08:48
Hot Stocks
Wayfair unveils real-time furniture delivery tracking »

Wayfair announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYSZ

MySize

$0.71

-0.0063 (-0.88%)

08:46
09/26/17
09/26
08:46
09/26/17
08:46
Hot Stocks
MySize awarded first patent »

My Size announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$53.23

-0.01 (-0.02%)

, ADDYY

adidas

$113.80

-1.22 (-1.06%)

08:45
09/26/17
09/26
08:45
09/26/17
08:45
Recommendations
Nike, adidas, Under Armour, lululemon analyst commentary  »

Survey respondents more…

NKE

Nike

$53.23

-0.01 (-0.02%)

ADDYY

adidas

$113.80

-1.22 (-1.06%)

UAA

Under Armour

$16.74

0.33 (2.01%)

LULU

lululemon

$57.39

-0.75 (-1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

SN

Sanchez Energy

$4.99

0.38 (8.24%)

, SHLD

Sears

$7.14

0.03 (0.42%)

08:45
09/26/17
09/26
08:45
09/26/17
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

SN

Sanchez Energy

$4.99

0.38 (8.24%)

SHLD

Sears

$7.14

0.03 (0.42%)

USO

United States Oil Fund

$10.55

0.31 (3.03%)

UCO

Universal Compression

$18.28

1.09 (6.34%)

JUNO

Juno Therapeutics

$42.33

-2.81 (-6.23%)

HIMX

Himax

$9.50

-0.66 (-6.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 08

    Nov

  • 14

    Nov

  • 16

    May

DDAIF

Daimler AG

$78.84

-0.86 (-1.08%)

, TSLA

Tesla

$344.99

-6.1 (-1.74%)

08:44
09/26/17
09/26
08:44
09/26/17
08:44
Periodicals
Daimler responds to Elon Musk tweet on electric vehicles, TechCrunch says »

Daimler (DDAIF) announced…

DDAIF

Daimler AG

$78.84

-0.86 (-1.08%)

TSLA

Tesla

$344.99

-6.1 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

DVCR

Diversicare

$11.10

0.1 (0.91%)

, OHI

Omega Healthcare

$32.45

0.36 (1.12%)

08:43
09/26/17
09/26
08:43
09/26/17
08:43
Hot Stocks
Diversicare, Omega Healthcare agree to terms of new master lease »

Diversicare Healthcare…

DVCR

Diversicare

$11.10

0.1 (0.91%)

OHI

Omega Healthcare

$32.45

0.36 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

DRI

Darden

$83.14

0.26 (0.31%)

08:43
09/26/17
09/26
08:43
09/26/17
08:43
Hot Stocks
Darden says expects impact of Hurricane Irma to be double that of Harvey »

Says Irma impact factored…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AMRS

Amyris

$3.21

-0.29 (-8.29%)

08:42
09/26/17
09/26
08:42
09/26/17
08:42
Hot Stocks
Amyris enters second product development, production agreement with Royal DSM »

Amyris announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VTR

Ventas

$66.62

0.58 (0.88%)

08:42
09/26/17
09/26
08:42
09/26/17
08:42
Conference/Events
The Executives' Club of Chicago holds a luncheon meeting »

The Executives' Club…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

08:40
09/26/17
09/26
08:40
09/26/17
08:40
General news
U.S. equities are mostly mildly firmer »

U.S. equities are mostly…

08:40
09/26/17
09/26
08:40
09/26/17
08:40
General news
Breaking General news story  »

Week of 9/23 Redbook to…

DRI

Darden

$83.14

0.26 (0.31%)

08:39
09/26/17
09/26
08:39
09/26/17
08:39
Hot Stocks
Breaking Hot Stocks news story on Darden »

Darden says Hurricane…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

NVDA

Nvidia

08:38
09/26/17
09/26
08:38
09/26/17
08:38
Technical Analysis
Technical View: Nvidia bounces back from prior session losses »

The shares were last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VCYT

Veracyte

$8.49

0.01 (0.12%)

08:38
09/26/17
09/26
08:38
09/26/17
08:38
Recommendations
Veracyte analyst commentary  »

Veracyte visibility…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

DRI

Darden

$83.14

0.26 (0.31%)

08:36
09/26/17
09/26
08:36
09/26/17
08:36
Hot Stocks
Darden says all businesses 'remain strong' »

Says to-go sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

TEUM

Pareteum

$1.06

0.01 (0.95%)

08:35
09/26/17
09/26
08:35
09/26/17
08:35
Hot Stocks
Breaking Hot Stocks news story on Pareteum »

Pareteum Corp trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVEE

NV5 Global

$53.85

2.15 (4.16%)

08:34
09/26/17
09/26
08:34
09/26/17
08:34
Hot Stocks
NV5 Global awarded $14M program management contract by Merced County »

NV5 Global announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

CSBR

Champions Oncology

$3.66

-0.09 (-2.40%)

08:33
09/26/17
09/26
08:33
09/26/17
08:33
Hot Stocks
Champions Oncology awarded $2M from National Cancer Institute »

Champions Oncology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$1.96

0.03 (1.55%)

, UNIT

Uniti Group

$17.36

0.85 (5.15%)

08:33
09/26/17
09/26
08:33
09/26/17
08:33
Hot Stocks
Windstream says allegations in purported notice of default 'without merit' »

In a regulatory filing…

WIN

Windstream

$1.96

0.03 (1.55%)

UNIT

Uniti Group

$17.36

0.85 (5.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

OSIS

OSI Systems

$85.81

-1.08 (-1.24%)

08:32
09/26/17
09/26
08:32
09/26/17
08:32
Hot Stocks
OSI Systems receives $16M in orders for ETD systems »

OSI Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.